T16A (p.Thr16Ala) variant of PDGFRA (P16234)

T16A (p.Thr16Ala) in PDGFRA (P16234) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.

T16A (p.Thr16Ala) variant details